XML 25 R11.htm IDEA: XBRL DOCUMENT v3.22.2
Trade Receivables
 6 Months Ended
Jun. 30, 2022
Receivables [Abstract]  
Trade Receivables Trade Receivables
Product Sales
Receivables from product sales are recorded for amounts due to the Company related to sales of ORLADEYO and RAPIVAB. At June 30, 2022 and December 31, 2021, receivables related to sales of ORLADEYO were $39,587 and $27,384, respectively. At June 30, 2022 and December 31, 2021, receivables related to sales of RAPIVAB were $61 and $49, respectively. No reserve or allowance amounts were recorded as of June 30, 2022 and December 31, 2021, respectively.
Collaborations
Receivables from collaborations were as follows (in thousands):
June 30, 2022
BilledUnbilledTotal
U.S. Department of Health and Human Services$— $1,303 $1,303 
Royalty receivables from partners540 — 540 
Total receivables$540 $1,303 $1,843 
December 31, 2021
BilledUnbilledTotal
U.S. Department of Health and Human Services$5 $1,670 $1,675 
Royalty receivables from partners305 — 305 
Total receivables$310 $1,670 $1,980 
As of both June 30, 2022 and December 31, 2021, the Company maintained a reserve of $701 related to royalties associated with Green Cross.